Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lars, Plaßmeier"'
Autor:
Stanislaus Reimer, Johan F. Lock, Sven Flemming, Alexander Weich, Anna Widder, Lars Plaßmeier, Anna Döring, Ilona Hering, Mohammed K. Hankir, Alexander Meining, Christoph-Thomas Germer, Kaja Groneberg, Florian Seyfried
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundEndoscopic vacuum therapy (EVT) is an evidence-based option to treat anastomotic leakages of the upper gastrointestinal (GI) tract, but the technical challenges and clinical outcomes of patients with large defects remain poorly described.Me
Externí odkaz:
https://doaj.org/article/43cc35d02ce44c6788ba976e23cae198
Autor:
Stanislaus, Reimer, Florian, Seyfried, Sven, Flemming, Markus, Brand, Alexander, Weich, Anna, Widder, Lars, Plaßmeier, Peter, Kraus, Anna, Döring, Ilona, Hering, Mohammed K, Hankir, Alexander, Meining, Christoph-Thomas, Germer, Johan F, Lock, Kaja, Groneberg
Publikováno v:
Surgical Endoscopy. 36:9169-9178
Background Endoscopic vacuum therapy (EVT) is an effective treatment option for leakage of the upper gastrointestinal (UGI) tract. The aim of this study was to evaluate the clinical impact of quality improvements in EVT management on patients’ outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665d38a1985e6580b9871cbd0f9e3ec6
https://doi.org/10.1007/s00464-022-09400-w
https://doi.org/10.1007/s00464-022-09400-w
Autor:
Richard F. Knoop, Moritz Sparn, Jens Waldmann, Lars Plassmeier, Detlef K. Bartsch, Matthias Lauth, Christoph Hudemann, Volker Fendrich
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 6, Pp 463-470 (2014)
BACKGROUND AND AIMS: BACKGROUND AND AIMSGemcitabine is the standard therapy for patients with pancreatic cancer with metastatic disease. Patients with metastatic pancreatic cancer presenting with increased values of C-reactive protein do not respond
Externí odkaz:
https://doaj.org/article/11c675ee518c463ca5ef00c36a778785
Publikováno v:
Visc Med
Background: Obesity is considered a risk factor for postoperative complications as it can limit exposure to the operation field, thereby significantly prolonging surgery time. Obesity-associated comorbidities, such as low-grade systemic inflammation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998bbe3c7e68770595563d0ff6456159
https://doi.org/10.1159/000517345
https://doi.org/10.1159/000517345
Autor:
Christina, Lenschow, Andreas, Wennmann, Anne, Hendricks, Christoph-Thomas, Germer, Martin, Fassnacht, Andreas, Buck, Rudolf A, Werner, Lars, Plassmeier, Nicolas, Schlegel
Publikováno v:
Langenbeck's archives of surgery. 407(8)
A successful focused surgical approach in primary hyperparathyroidism (pHPT) relies on accurate preoperative localization of the parathyroid adenoma (PA). Most often, ultrasound is followed by [A single-center retrospective analysis of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47451c1efac2ea4e503ad84e370a244e
https://pubmed.ncbi.nlm.nih.gov/35945299
https://pubmed.ncbi.nlm.nih.gov/35945299
Autor:
Katica Krajinovic, Caroline Corteville, Christian Jurowich, Armin Wiegering, Christoph-Thomas Germer, Lars Plaßmeier, Ulrich A. Dietz
Publikováno v:
International Journal of Colorectal Disease. 32:291-293
Perineal wound healing disorders are one of the major complications following abdominoperineal rectum extirpation.We evaluated the impact of an "incisional negative pressure wound therapy" (iNPWT) system after abdominoperineal rectum extirpation in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d38e377f6ab18e9abe89c424c7c53f
https://doi.org/10.1007/s00384-016-2704-5
https://doi.org/10.1007/s00384-016-2704-5
Autor:
Volker Fendrich, Matthias Lauth, Richard Knoop, Lars Plassmeier, Jens Waldmann, Detlef K. Bartsch, Moritz Sparn
Publikováno v:
Pancreatology. 13:502-507
Background and aims Pancreatic cancer is among the most dismal of human malignancies. There are no chemopreventive strategies for pancreatic cancer or its precursor lesions, pancreatic intraepithelial neoplasia (PanINs). Recent evidence suggests that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f30bc83d5861e6dc077e5e0a61b9642d
https://doi.org/10.1016/j.pan.2013.08.002
https://doi.org/10.1016/j.pan.2013.08.002
Autor:
Matthias Lauth, Detlef K. Bartsch, Volker Fendrich, Lars Plassmeier, Jens Waldmann, Richard Knoop, Christoph Hudemann, Moritz Sparn
Publikováno v:
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 6, Pp 463-470 (2014)
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 6, Pp 463-470 (2014)
BACKGROUND AND AIMS: BACKGROUND AND AIMSGemcitabine is the standard therapy for patients with pancreatic cancer with metastatic disease. Patients with metastatic pancreatic cancer presenting with increased values of C-reactive protein do not respond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239a2fee34a32c38c6f72e0e40a124ae
https://pubmed.ncbi.nlm.nih.gov/24953430
https://pubmed.ncbi.nlm.nih.gov/24953430
Autor:
Jens Waldmann, Stefan Fichtner-Feigl, Malte Buchholz, Detlef K. Bartsch, Volker Fendrich, Rebecca Kesselring, Lars Plassmeier, Richard Knoop
Publikováno v:
130. Kongress der Deutschen Gesellschaft für Chirurgie; 20130430-20130503; München; DOC13dgch686 /20130426/
Introduction: Gemcitabine became the reference regimen for advanced pancreatic cancer after a randomized trial showed significant improvement in the median overall survival. Since then the combination of gemcitabine with a variety of cytotoxic and ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8776ea9b874d4b40bf28e3d1f39991f9
